Professor of Addiction Psychiatry, Academic Medical Center of the University of Amsterdam
Wim van den Brink (1952) received his medical degree in 1981 from the Free University in Amsterdam. After his training as a psychiatric epidemiologist in Groningen (1983-1986) and New York (1986-1987), he received his PhD degree form the State University of Groningen in 1989.
Since 1992, he has been full professor of Addiction Psychiatry at the Academic Medical Center of the University of Amsterdam. Wim van den Brink is also the director of the Amsterdam Institute for Addiction Research (AIAR).
In 2014, Wim van den Brink received the life time achievement award for science from the Netherlands Association of Psychiatry and in 2015, he was granted the status of honorable member of the Spanish Society for Dual disorders.
Wim van den Brink is also a (co)author of more than 500 international peer reviewed scientific papers (WoS HI=60) and has been a thesis advisor of more than 70 PhD students. Currently, he is one of the chief-editors of European Addiction Research and he has been the chair of the Workgroups that developed the Dutch Interdisciplinary Treatment Guidelines on Alcohol Use Disorders, Opiate Addiction and Drugs other than opioids.
Wim van den Brink is president of the International Collaboration of ADHD and Substance Abuse (ICASA) and was the chair of the Scientific Program Committee of European College of Neuropsychopharmacology (ECNP). His main scientific interests are related to the neurobiology of substance use disorders and behavioral addictions, the pharmacological treatment of substance use disorders and related comorbidities, and the reduction of stigma regarding patients with an addiction.
- Received grants/research supports from Alkermes.
- Received honoraria or consultation fees from Lundbeck, Indivior, Mundipharma, D&A Pharma, BioProject, Novartis, Kinnov Therapeutics, Opiont Therapeutics.
- Participated in Infivior, Luncbeck, Eli Lilly, Pfizer’s sponsored speaker’s bureau.